Guillaume Levilain
5Patents
3h-index
8Co-inventors
46Inventor score
Filing activity: Mar 26, 2010 → Sep 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8546344B2 | Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole | Chemistry; Metallurgy | 8 | Active |
| US11130777B2 | Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-1H-benzimidazole | Chemistry; Metallurgy | 4 | Active |
| US8742102B2 | Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization | Human Necessities | 4 | Active |
| US8907106B2 | Process for the resolution of enantiomers by preferential evaporative crystallization | Chemistry; Metallurgy | 1 | Active |
| US12060382B2 | Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.